Technological advancements in fields such as molecular genetics and the human microbiome have resulted in an unprecedented recognition of new bacterial genus/species designations by the International Journal of Systematic and Evolutionary Microbiology. Knowledge of designations involving clinically significant bacterial species would benefit clinical microbiologists in the context of emerging pathogens, performance of accurate organism identification, and antimicrobial susceptibility testing. In anticipation of subsequent taxonomic changes being compiled by the Journal of Clinical Microbiology on a biannual basis, this compendium summarizes novel species and taxonomic revisions specific to bacteria derived from human clinical specimens from the calendar years 2012 through 2015.
H uman microbiome studies, particularly those involving genome sequencing, have resulted in a seeming explosion of novel bacterial taxonomy. While many of these organisms appear to play a commensal role in site-specific ecology, some of the organisms may be of clinical significance in various patient populations. Moreover, enhanced studies of known bacterial genomes in a variety of applications, including those of an epidemiologic nature, have given rise to revisions and amendments to accepted bacterial taxonomy. Summaries of microbial taxonomy updates, such as those introduced in this edition of the Journal of Clinical Microbiology, are essential to routine practice in the clinical microbiology laboratory.
Since 2014, laboratories subscribing to the College of American Pathologists accreditation program have encountered checklist standard MIC.11375 in the context of biennial inspection exercises. The standard (1) requires laboratories to assimilate "taxonomic changes that potentially affect the choice of appropriate antimicrobials to report and/or the interpretative breakpoints to use." Cited as an example for the context of this standard is the Gram-negative bacillus with the former taxonomic designation Actinobacillus actinomycetemcomitans. The taxonomic revision in 1985 (2) resulting in organism classification within the genus Haemophilus subsequently enabled antimicrobial susceptibility testing of clinically significant isolates using standards outlined in Table 2E of CLSI supplement M100S (example provided in [3] ). Haemophilus test medium, with a 16-to 18-hour incubation in 5% CO 2 enrichment, could be utilized for disk diffusion. Haemophilus test medium broth could also be inoculated for broth microdilution testing with 20-to 24-hour incubation in ambient air.
Subsequent reclassification of this organism into the genus Aggregatibacter (4) has resulted in the transition of susceptibility testing guidelines to those specific to (former) HACEK group organisms (Aggregatibacter spp., Cardiobacterium spp., Eikenella corrodens, and Kingella spp.) in Table 9 of the CLSI guideline M45 (5) .
81% of Elizabethkingia spp. bacteremic episodes were related to E. anophelis, as confirmed by full-gene 16S rRNA sequencing. The mortality rate in these patients was 23 .5% (4/17) , while none of the three E. meningoseptica bacteremia cases was fatal. Patients with E. anophelis bacteremia carried additional clinical diagnoses of community-acquired or nosocomial pneumonia (29.4% of cases), catheter-related bacteremia (23.5%), and neonatal meningitis (17.6%).
Analogous to the original Hong Kong report (9) , all E. anophelis isolates were originally identified as E. meningoseptica by a commercial biochemical system; nearly 60% were identified as E. meningoseptica by MALDI-TOF MS. Database revision by the addition of seven E. anophelis spectra facilitated the identification of all E. anophelis isolates. An increased resistance to piperacillin and co-trimoxazole was observed within the E. anophelis collection compared to that of the limited subset of E. meningoseptica isolates (10) . In summary, the recognition of current bacterial taxonomy can assist in future epidemiologic and prognostic delineations of Elizabethkingia spp. infections and additional emerging infectious agents.
Attempts to summarize and centralize taxonomic changes into a single resource were previously undertaken (11, 12) , and there have been recent attempts to renew this practice (13, 14) . The following compendium of clinically significant bacterial taxonomy changes from the calendar years 2012 to 2015 attempts to provide a comprehensive capstone for the biannual updating of bacterial taxonomy by editors of the Journal of Clinical Microbiology.
METHODS AND DATA
Validly published novel (Table 1 ) and revised ( Table 2 ) taxa pertinent to prokaryotic species must meet one of two requirements: (i) an original investigation published in the International Journal of Systematic and Evolutionary Microbiology (IJSEM) or (ii) a study published in an alternative journal, with later inclusion on an approved list in IJSEM. Journals that publish studies reporting new taxa that may be relevant to the practice of clinical microbiology include Antonie Van Leeuwenhoek, Current Microbiology, International Journal of Medical Microbiology, Standards in Genomic Sciences, and Systematic and Applied Microbiology. Six times per year, IJSEM publishes papers entitled "List of new names and new combinations previously effectively, but not validly, published" (example provided in [69] ). To be considered for inclusion on this approved list, authors must submit a copy of the published manuscript to the editorial office of IJSEM for confirmation that all the elements necessary for valid publication have been met. In addition, type strains are to be deposited into two recognized culture collections in separate nations. Taxa on these approved lists may be subject to reclassification on the basis of a synonym designation or transfer to another genus. Accepted taxa within Tables 1 and 2 that were previously published outside IJSEM are represented by appropriate footnoting.
In such fashion, all issues of IJSEM that were published between January 2012 and December 2015 were searched for original articles describing new species taxonomy or for accepted changes in taxonomic nomenclature. This audit was further filtered by organisms recovered from human sources. When an initial organism reservoir could not be ascertained, PubMed primary literature searches (U.S. National Library of Medicine and the National Institutes of Health) of the novel or revised taxon were utilized to attempt to index subsequent case reports for further investigation; several of these case reports are referenced throughout this report. A number of IJSEM publications (examples provided in [35, [70] [71] [72] [73] [74] [75] ) simply identified isolates as being derived from a specific specimen source (including sterile body sites), but did not provide contextual clinical data. Therefore, in these scenarios (including a number of novel taxa derived from blood culture), clinical significance of these taxa was interpreted as "not established." Future studies may be necessary to characterize the true clinical significance of novel taxa (76) .
Twice per year, IJSEM publishes papers entitled "Notification of changes in taxonomic opinion previously published outside the IJSEM." The journal publicizes these changes in taxonomic opinion simply as a service to bacteriology, rather than statements of validly published or approved taxonomy. Two such examples of taxonomic opinion (77, 78) are presented in Table 2 , with antecedent primary referenced literature (79, 80) . These entries have been included with the goal of revisiting them in future Journal of Clinical Microbiology compendia to either ascertain true clinical significance or to determine if official taxonomic status has been granted. Table 1 lists the new taxa recovered from humans stratified by Gram reaction and morphology. Many of the new genera and species were likely discovered from studies of the human microbiome. Much of what is listed, while recovered from human clinical material, has unknown clinical significance. There are a few exceptions that warrant emphasis.
RESULTS AND DISCUSSION

GRAM-POSITIVE COCCI
Seven new Streptococcus species were characterized during the study period, as highlighted in Table 1 . Streptococcus tigurinus, a new member of the Streptococcus mitis group, was discovered by Zbinden et al. in 2012, when it was recovered from the blood and aortic valve of a 74-year-old Swiss patient with endocarditis (15, 16) . The authors performed a retrospective review of their institution's 16S rRNA gene sequence database in the 10-year period prior to 2012, and a total of 15 patients with S. tigurinus infections were discovered (16) . A review of the charts revealed that all of the infections were serious and invasive and included 12 cases of bacteremia, seven of which were from patients with endocarditis (16) . Other invasive infections included spondylodiscitis, prosthetic joint infections, meningitis, encephalitis, and empyema (16) . Others have subsequently reported similar severe infections in patients from Korea (17) , Japan (18) , and the United States (19) . The high virulence potential of this organism has been demonstrated in a rat model of endocarditis wherein it was demonstrated that S. tigurinus strains have increased abilities to resist macrophage-mediated phagocytosis and to invade endothelial cells (20) . The oral cavity is the presumed source of the organism. An initial study found that this organism was not prevalent in the saliva of healthy volunteers (16) . However, using more sensitive molecular techniques, the same group obtained saliva and pooled plaque samples from a non-periodontitis control group and a group with periodontitis (21) . The overall prevalence of S. tigurinus was 53% in 51 patients and there was no difference in the frequencies of detection between the two groups (21) . MALDI-TOF MS misidentifies S. tigurinus as Streptococcus oralis, Streptococcus pneumoniae, or other member of the mitis group with scores Ͼ2.0 (16, 19, 22) . Identification requires the use of 16S rRNA partial or full-gene sequencing or other molecular methods (21) .
Two new subspecies of the coagulase-negative Staphylococcus petrasii have been characterized. Subspecies jettensis was recovered from wounds and implicated in bacteremia, whereas subspecies pragensis is believed to have caused prostatitis (23) (24) (25) . One new species of coagulase-positive Staphylococcus, Staphylococcus argenteus, was isolated from the blood of a person in Australia. This organism is phenotypically very similar to S. aureus and has likely been misidentified as such (26) . The 16S rRNA gene sequence (1,474 nucleotide [nt]) of S. argenteus is identical to that of S. aureus. However, whole-genome sequencing indicates that they are separate species. In addition, the proteomics profile of S. argenteus using MALDI-TOF MS is different from that of S. aureus (26) . A study in Thailand demonstrated that 4.1% of isolates believed to be S. aureus were subsequently determined to be S. argenteus (27) . This organism was associated primarily with community-acquired skin and soft tissue infections, although bacteremia and bone and joint infections were seen in three and two patients, respectively (27) .
Similar to other Gemella species, the two new additions to the genus, G. taiwanensis and G. parahaemolysans, were isolated from blood cultures and are believed to be a Taxonomic designation subsequently accepted in validation list no. 144 (146) .
b
Taxonomic designation subsequently accepted in validation list no. 146 (147) .
c Taxonomic designation subsequently accepted in validation list no. 149 (148) .
d
Taxonomic designation subsequently accepted in validation list no. 155 (149) .
e Taxonomic designation subsequently accepted in validation list no. 152 (150) .
f Taxonomic designation subsequently accepted in validation list no. 158 (151) .
g Taxonomic designation subsequently accepted in validation list no. 157 (60) .
h Taxonomic designation subsequently accepted in validation list no. 163 (152) .
i BSK medium is the name applied to a selective medium used to grow the Lyme disease spirochete. BSK-K5 has kanamycin and 5 fluorouracil.
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Journal of Clinical Microbiology cause of opportunistic infections in immunocompromised patients (28) . All of the patients from whom these isolates were recovered had significant comorbidities, including various types of solid tumors (28) . These organisms grow slowly on 5% sheep blood agar and are nonhemolytic. They are easily decolorized during Gram staining (28) . Biochemical tests can be used to differentiate them from other species of Gemella (28) .
GRAM-POSITIVE RODS
Many aerobic or facultatively anaerobic Gram-positive rods were discovered during the 4-year period of this review. The new species of lactobacilli were recovered from the feces of patients who were otherwise healthy and likely represent a component of the normal intestinal microbiota (29, 30) . Several new aerobic actinomycetes in the Nocardia and Gordonia genera were recovered from patients with pneumonia, thereby contributing to the growing list of opportunistic pathogens in immunocompromised patients. Two new genera were also described. Hazenella coriacea grows optimally between 42 and 45°C and was recovered from the blood of three separate patients, although the details of their illnesses were not provided (31) . Canibacter oris was recovered from both a swab and purulent material from an infected dog-bite wound on the finger of a 58-year-old patient in Australia (32) .
GRAM-NEGATIVE COCCI
Two new Gram-negative cocci have been characterized. Neisseria oralis (33) is a new species that is found in the human oral cavity and is associated with a variety of infections. The clinical significance of the new genus and species Faucicola mancuniensis, recovered from the tonsils of an otherwise healthy woman, has not been established (34) .
FACULTATIVE GRAM-NEGATIVE RODS
With respect to novel Gram-negative bacillus taxa, the oxidase-positive Psychrobacter sanguinis sp. nov. was first identified from four archival blood culture isolates originating from New York (35) . Clinical significance was uncertain among any of these cases, as pertinent clinical data were not provided. Full-gene 16S rRNA sequencing reported 99.7% genetic similarity to Psychrobacter sp. PRwf-1, a strain originating from a fish species caught in Puerto Rico. The aquatic strain was subsequently reclassified as P. sanguinis. A French group recently reported a case of post-neurosurgical meningitis with P. sanguinis etiology (36) . An external ventricular drain was instilled into a 64-year-old female to relieve elevated intracranial pressure. Approximately 1 week after the procedure, the organism was cultivated following a lumbar puncture. It was hypothesized that the patient repeatedly touched the drain with her bare hands, facilitating the introduction of organisms from an environmental (nosocomial) source.
In 1985, Harvey and Greenwood (37) reported the isolation of Campylobacter fetus from a pet turtle in the context of three clinically ill household members and concomitant isolation of Salmonella enterica serovar Agona. Molecular analysis of a C. fetus subsp. fetus blood culture isolate derived from a precursor T lymphocyte acute lymphoblastic leukemia patient indicated a reptilian origin (38) . This isolate and other archival human strains were paired with five C. fetus-like organisms from reptiles, subjected to a number of characterizations (including MALDI-TOF MS and wholegenome sequencing), and granted the novel taxon Campylobacter fetus subsp. testudinum subsp. nov. (39) . Epidemiologic investigation indicated that afflicted individuals were largely Asian men who reported consumption of Asian foods or had previous exposure to reptiles (40) .
ANAEROBES
Many new anaerobes have been discovered. Some have been recovered from the stool of healthy children and adults and likely represent components of the normal microbiota. Others have been isolated from dental plaque, but whether they cause periodontal disease is unclear at present. A few organisms are worth highlighting.
Among the Gram-positive anaerobes, two new Peptoniphilus species, namely, duerdenii and koenoeneniae were recovered from abscesses of the vagina and buttocks, respectively (41) . Actinobaculum schaalii has been moved into the genus Actinotignum. The three species in this genus, schaalii, urinale, and sanguinis, are part of the urinary microbiota, but they are also associated with urinary tract infections in men and young children (42) . MALDI-TOF MS can identify these species, and the correct identification is important, as A. schaalii, the most common pathogen in the genus, is resistant to trimethoprim-sulfamethoxazole and ciprofloxacin, which are the agents commonly used for the treatment of urinary tract infections (42) . Atopobium deltae, another novel Gram-positive anaerobe, was recovered from the blood of a patient with Fournier's gangrene (43) . Most of the newly discovered Gram-negative anaerobes have not been clearly associated with clinical infections, except for the new genus and species Eisenbergiella tayi (44) , which was associated with bacteremia in an elderly patient. Of the spirochetes recently characterized, Leptospira mayottensis has been associated with clinical disease in patients from Mayotte in the Indian Ocean (45) . Table 2 lists the taxonomic revisions for organisms recovered from humans, stratified by Gram reaction and morphology. A recent report describing the successful culture propagation of what was formerly classified as "Candidatus Helicobacter heilmannii" from feline gastric mucosa resulted in its assignment to the taxon Helicobacter heilmannii sp. nov. (46) . While most descriptions of this organism are associated with veterinary bacteriology, evidence does exist for the presence of this organism in human tissue (reviewed in reference 47).
TAXONOMIC REVISIONS
Aeromonas hydrophila subsp. dhakensis and Aeromonas aquariorum were reclassified in 2013 under the singular taxon Aeromonas dhakensis sp. nov. comb. nov. (48) . Formal acceptance by the IJSEM was granted in 2015 (49) . The initial characterization of A. hydrophila subsp. dhakensis occurred in the context of diarrheal illness in Bangladesh (50) . In addition to gastroenteritis, reports have suggested a significant distribution of (the former) A. aquariorum extraintestinal infections in a variety of geographic locations (51, 52) . Chen et al. (53) reviewed 80 cases of Aeromonas spp. wound infections in Taiwan. It was found that 46.3% of these infections were caused by A. dhakensis, while 16.3% were of A. hydrophila etiology. Compared to other Aeromonas spp., A. dhakensis was also associated with antecedent environmental water exposure, biofilm formation, and increased in vitro cytotoxicity. Furthermore, the organism generated increased MIC values for ceftriaxone, gentamicin, and imipenem.
Wautersiella falsenii was reclassified in 2014 as Empedobacter falsenii comb. nov. (54) . Twenty-six human isolates from Belgium (including blood, ear discharge, oral cavity, pleural fluid, pus, respiratory tract, wound, and vaginal swab) contributed to the initial W. falsenii designation (55) . Again, clinical manifestations of illness were not described in this report. van der Velden et al. (56) presented the case of a febrile 1-year-old girl with pyelonephritis caused by W. falsenii. The identification of the organism was facilitated by MALDI-TOF MS and confirmed by partial-gene 16S rRNA sequencing. An intravenous 2-week ciprofloxacin regimen brought about clinical and microbiologic improvement. Traglia et al. (57) described the isolation of E. falsenii from a cervical neck abscess specimen obtained from an 18-year-old female with acute otitis media. Similar to the previous clinical report (56) , the E. falsenii isolate exhibited decreased susceptibilities to colistin, ceftazidime, piperacillin-tazobactam, representative carbapenems, and additional ␤-lactam/␤-lactamase inhibitor combinations.
POTENTIAL EMERGING PATHOGENS
While not included within the formal tables of this review, the following encompass examples of new taxa that could conceivably transcend into the realm of human clinical disease. Rickettsia buchneri sp. nov. (58) is a Gram-negative bacillus isolated from ovaries of the Ixodes scapularis vector already known to deliver a number of bacterial and parasitic species to accidental human hosts. Mediannikov et al. (59) isolated and characterized the Gram-negative bacillus Bartonella senegalensis sp. nov. from the soft tick Ornithodoros sonrai, a vector of relapsing fever. This novel taxon was subsequently approved by IJSEM (60) . Klebsiella michiganensis sp. nov. (61) is a newly characterized Gram-negative bacillus isolated from a toothbrush holder, with taxonomy subsequently accepted by IJSEM (62). Brady et al. (63) described taxonomic reclassification of Enterobacter oryzae and Enterobacter turicensis as Kosakonia oryzae comb. nov. and Cronobacter zurichensis nom. nov., respectively, with subsequent acceptance by IJSEM (64). In antecedent publications, the former E. oryzae and E. turicensis were recovered from wild rice (65) and fruit (77) . c Taxonomic designation subsequently accepted in validation list no. 154 (64) . d Taxonomic designation subsequently accepted in validation list no. 155 (149) . e Taxonomic designation not recognized on validation list in International Journal of Systematic and Evolutionary Microbiology; offered as component of changes in taxonomic opinion no. 22 (78) . powder (66), respectively. Stephan et al. (67) published the taxonomic reclassification of Enterobacter pulveris as Franconibacter pulveris comb. nov. Isolation of this organism from infant formula was previously described (68) . These organisms with inferred pathogenic potential provide the basis for follow-up database searches in future Journal of Clinical Microbiology taxonomy compendia.
In summary, over the 4-year period of this review, both the expansion of new technologies and the characterization of the human microbiome have led to the discovery of a broad range of bacterial organisms that are part of the normal human microbiota. In addition, the new tools have enabled a more comprehensive assessment of closely related pathogens and the discovery of novel clinically significant organisms. We attempted to highlight those pathogens and, where possible, to describe their epidemiologic and clinical niches.
